Compact diagnostics Micronics specializes in near-patient in vitro diagnostic products using microfluidics to miniaturize complex tests onto credit card size disposable devices, presenting opportunities to position compact diagnostic solutions to clinics, point-of-care labs, and ambulatory care centers.

Diverse assays Product applications include immunoassays, nucleic acid assays, protein crystallography, and DNA sequencing on integrated disposable devices, suggesting cross-sell potential across multiple assay workflows and rapid expansion into new test panels.

Growing revenue Current revenue is in the low single-digit millions to under ten million, indicating a market-ready product with room for scale through expanded client base, pilot programs, and strategic partnerships in biotech and clinical settings.

SME footprint With 11-50 employees, Micronics represents a small-to-mid sized organization likely receptive to flexible collaboration models, co-development agreements, and speed-to-market partnerships with larger systems integrators or distributors.

Strategic partnerships Compared to larger players, there is potential to anchor collaborations with mid-market distributors or contract research organizations seeking microfluidic disposable platforms, leveraging their networks to accelerate adoption and geographic reach.